Medicines planning
47 results
Applied filters
Planning
We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.
Preparing to use ranibizumab biosimilar
5 November 2025Ranibizumab biosimilar needs planning. Ensure you are familiar with the area and then develop an implementation plan working with the multidisciplinary team
Costing clinical trials of ATIMPs using the NIHR iCT
11 February 2026Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.
New Medicines News
9 April 2026New Medicines News is produced by the SPS Horizon Scanning Service. It highlights recent new product launches and significant medicines regulatory changes.
Good governance when implementing natalizumab biosimilar
11 December 2024Governance should consider processes for approval, procurement and supply, prescribing and administration, monitoring and pharmacovigilance.
Preparing to use golimumab biosimilar
9 January 2026One golimumab biosimilar (Gobivaz) is available. We offer general information and implementation advice.
Exagamglogene autotemcel (Casgevy®)
13 February 2026This document highlights key areas where Chief Pharmacists should focus pharmaceutical expertise prior to implementation of exagamglogene autotemcel.
Have your say: biosimilars and patents resources
20 May 2026We are reviewing Specialist Pharmacy Service (SPS) resources on biosimilars and patents to ensure they meet the needs of NHS services.
National Homecare Medicines Committee (NHMC) managing complaints and incidents within homecare services - Appendix 19 training
2 July 2018Find and download the NHMC managing homecare complaints and incidents workbook
National Homecare Medicines Committee (NHMC) Homecare Risk Assessment
10 December 2019Find attached the homecare risk assessment spreadsheet to download